107 related articles for article (PubMed ID: 12760727)
1. Short- and medium-term clinical efficacy of three endoscopic therapies for achalasia: a single-blinded prospective study.
Caunedo A; Romero R; Hergueta P; Gómez BJ; Rodríguez-Téllez M; Linares E; Sánchez-Gey S; Pellicer FJ; Herrerías JM
Rev Esp Enferm Dig; 2003 Jan; 95(1):13-21, 22-9. PubMed ID: 12760727
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy of Botulinum toxin in classical achalasia: a prospective study.
Kolbasnik J; Waterfall WE; Fachnie B; Chen Y; Tougas G
Am J Gastroenterol; 1999 Dec; 94(12):3434-9. PubMed ID: 10606299
[TBL] [Abstract][Full Text] [Related]
3. Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin.
Neubrand M; Scheurlen C; Schepke M; Sauerbruch T
Endoscopy; 2002 Jul; 34(7):519-23. PubMed ID: 12170400
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter.
Fishman VM; Parkman HP; Schiano TD; Hills C; Dabezies MA; Cohen S; Fisher RS; Miller LS
Am J Gastroenterol; 1996 Sep; 91(9):1724-30. PubMed ID: 8792688
[TBL] [Abstract][Full Text] [Related]
5. Use of botulinum toxin as a diagnostic/therapeutic trial to help clarify an indication for definitive therapy in patients with achalasia.
Katzka DA; Castell DO
Am J Gastroenterol; 1999 Mar; 94(3):637-42. PubMed ID: 10086644
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin injections for achalasia symptoms can approximate the short term efficacy of a single pneumatic dilation: a survival analysis approach.
Prakash C; Freedland KE; Chan MF; Clouse RE
Am J Gastroenterol; 1999 Feb; 94(2):328-33. PubMed ID: 10022624
[TBL] [Abstract][Full Text] [Related]
7. [Intrasphincteric injection of botulinum toxin in patients with esophageal achalasia].
Zapata R; Carvajal S; Alvarez M; González R; Chianale J; Rollán A
Rev Med Chil; 1997 Aug; 125(8):899-904. PubMed ID: 9567393
[TBL] [Abstract][Full Text] [Related]
8. Intrasphincteric botulinum toxin for the treatment of achalasia.
Pasricha PJ; Ravich WJ; Hendrix TR; Sostre S; Jones B; Kalloo AN
N Engl J Med; 1995 Mar; 332(12):774-8. PubMed ID: 7862180
[TBL] [Abstract][Full Text] [Related]
9. Effect of botulinum toxin injection for achalasia in Thai patients.
Leelakusolvong S; Sinpeng T; Pongprasobchai S; Tanwandee T; Kachintorn U; Manatsathit S
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S67-72. PubMed ID: 17718248
[TBL] [Abstract][Full Text] [Related]
10. Injection of botulinum toxin before pneumatic dilatation in achalasia treatment: a randomized-controlled trial.
Mikaeli J; Bishehsari F; Montazeri G; Mahdavinia M; Yaghoobi M; Darvish-Moghadam S; Farrokhi F; Shirani S; Estakhri A; Malekzadeh R
Aliment Pharmacol Ther; 2006 Sep; 24(6):983-9. PubMed ID: 16948810
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pneumatic dilation with pneumatic dilation plus botulinum toxin for treatment of achalasia.
Bakhshipour A; Rabbani R; Shirani S; Soleimani HA; Mikaeli J
Acta Med Iran; 2010; 48(2):107-10. PubMed ID: 21133003
[TBL] [Abstract][Full Text] [Related]
12. Short-term and long-term results of endoscopic balloon dilation for achalasia: 12 years' experience.
Chan KC; Wong SK; Lee DW; Mui WL; Chan AC; Ng EK; Wu JC; Sung JJ; Chung SC
Endoscopy; 2004 Aug; 36(8):690-4. PubMed ID: 15280973
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of esophageal botulinum toxin injection in high-risk achalasia patients.
Gordon JM; Eaker EY
Am J Gastroenterol; 1997 Oct; 92(10):1812-7. PubMed ID: 9382042
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicentre randomised controlled trial with a 2-year follow-up.
Ouvry P; Allaert FA; Desnos P; Hamel-Desnos C
Eur J Vasc Endovasc Surg; 2008 Sep; 36(3):366-70. PubMed ID: 18524643
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction.
Miller LS; Pullela SV; Parkman HP; Schiano TD; Cassidy MJ; Cohen S; Fisher RS
Am J Gastroenterol; 2002 Jul; 97(7):1640-6. PubMed ID: 12135012
[TBL] [Abstract][Full Text] [Related]
16. Achalasia. A new modality for treatment.
Mitchell RE; Mitchell RE; Mitchell RG
Va Med Q; 1995; 122(3):184-5. PubMed ID: 7612684
[TBL] [Abstract][Full Text] [Related]
17. Complexities of managing achalasia at a tertiary referral center: use of pneumatic dilatation, Heller myotomy, and botulinum toxin injection.
Vela MF; Richter JE; Wachsberger D; Connor J; Rice TW
Am J Gastroenterol; 2004 Jun; 99(6):1029-36. PubMed ID: 15180721
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up after pneumatic dilation for achalasia cardia: factors associated with treatment failure and recurrence.
Ghoshal UC; Kumar S; Saraswat VA; Aggarwal R; Misra A; Choudhuri G
Am J Gastroenterol; 2004 Dec; 99(12):2304-10. PubMed ID: 15571574
[TBL] [Abstract][Full Text] [Related]
19. Treatment with botulinum toxin of octo-nonagerians with oesophageal achalasia: a two-year follow-up study.
Bassotti G; D'Onofrio V; Battaglia E; Fiorella S; Dughera L; Iaquinto G; Mazzocchi A; Morelli A; Annese V
Aliment Pharmacol Ther; 2006 Jun; 23(11):1615-9. PubMed ID: 16696811
[TBL] [Abstract][Full Text] [Related]
20. Treatment of achalasia with the Witzel dilator: a prospective randomized study of two methods.
Alonso-Aguirre P; Aba-Garrote C; Estévez-Prieto E; González-Conde B; Vázquez-Iglesias JL
Endoscopy; 2003 May; 35(5):379-82. PubMed ID: 12701006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
